79 related articles for article (PubMed ID: 3416313)
1. In vivo 31P nuclear magnetic resonance spectroscopy of subcutaneous 9L gliosarcoma: effects of tumor growth and treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea on tumor bioenergetics and histology.
Sijens PE; Bovee WM
Cancer Res; 1988 Oct; 48(19):5610-1. PubMed ID: 3416313
[No Abstract] [Full Text] [Related]
2. In vivo 31P nuclear magnetic resonance spectroscopy of subcutaneous 9L gliosarcoma: effects of tumor growth and treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea on tumor bioenergetics and histology.
Steen RG; Tamargo RJ; McGovern KA; Rajan SS; Brem H; Wehrle JP; Glickson JD
Cancer Res; 1988 Feb; 48(3):676-81. PubMed ID: 3335030
[TBL] [Abstract][Full Text] [Related]
3. Effects of chemotherapy by 1,3-bis(2-chloroethyl)-1-nitrosourea on single-quantum- and triple-quantum-filtered 23Na and 31P nuclear magnetic resonance of the subcutaneously implanted 9L glioma.
Winter PM; Poptani H; Bansal N
Cancer Res; 2001 Mar; 61(5):2002-7. PubMed ID: 11280759
[TBL] [Abstract][Full Text] [Related]
4. Sensitization of 9L rat brain gliosarcoma cells to 1,3-bis(2-chloroethyl)-1-nitrosourea by alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor.
Hung DT; Deen DF; Seidenfeld J; Marton LJ
Cancer Res; 1981 Jul; 41(7):2783-5. PubMed ID: 6788362
[TBL] [Abstract][Full Text] [Related]
5. Growth kinetics and treatment response of the intracerebral rat 9L brain tumor model: a quantitative in vivo study using magnetic resonance imaging.
Kim B; Chenevert TL; Ross BD
Clin Cancer Res; 1995 Jun; 1(6):643-50. PubMed ID: 9816027
[TBL] [Abstract][Full Text] [Related]
6. Invasive phenotype observed in 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant sublines of 9L rat glioma cells: a tumor model mimicking a recurrent malignant glioma.
Saito R; Bringas J; Mirek H; Berger MS; Bankiewicz KS
J Neurosurg; 2004 Nov; 101(5):826-31. PubMed ID: 15540922
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy with 1,3-bis(2-chloroethyl)-1-nitrosourea and low dose rate radiation in the 9L rat brain tumor and spheroid models: implications for brain tumor brachytherapy.
Gutin PH; Bernstein M; Sano Y; Deen DF
Neurosurgery; 1984 Dec; 15(6):781-6. PubMed ID: 6514150
[TBL] [Abstract][Full Text] [Related]
8. In vivo 31P nuclear magnetic resonance spectroscopy of rat 9L gliosarcoma treated with BCNU: dose response of spectral changes.
Steen RG; Tamargo RJ; Brem H; Glickson JD; Wehrle JP
Magn Reson Med; 1989 Aug; 11(2):258-66. PubMed ID: 2779416
[TBL] [Abstract][Full Text] [Related]
9. [Kinetics of multicellular spheroids developed from a human glioblastoma, and effect of 1,3-bis (2-chloroethyl)-1-nitrosourea].
Pertuiset BF; Rosenblum ML; Poisson M; Hauw JJ; Deen DF; Buge A
Sem Hop; 1983 Feb; 59(7):468-72. PubMed ID: 6302887
[TBL] [Abstract][Full Text] [Related]
10. Differential potentiation of 1,3-bis(2-chloroethyl)-1-nitrosourea by alpha-difluoromethylornithine in chloroethylnitrosourea-sensitive and -resistant 9L rat brain tumor cells in vitro.
Oredsson SM; Tofilon PJ; Feuerstein BG; Deen DF; Rosenblum ML; Marton LJ
Cancer Res; 1983 Aug; 43(8):3576-8. PubMed ID: 6407751
[TBL] [Abstract][Full Text] [Related]
11. Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging.
Chenevert TL; McKeever PE; Ross BD
Clin Cancer Res; 1997 Sep; 3(9):1457-66. PubMed ID: 9815831
[TBL] [Abstract][Full Text] [Related]
12. Cell cycle age response of 9L cells to 1,3-bis(2-chloroethyl)-1-nitrosourea and modification by alpha-difluoromethylornithine.
Bjerkvig R; Oredsson SM; Marton LJ; Linden M; Deen DF
Cancer Res; 1983 Apr; 43(4):1497-500. PubMed ID: 6403224
[TBL] [Abstract][Full Text] [Related]
13. Predicting and monitoring response to chemotherapy by 1,3-bis(2-chloroethyl)-1-nitrosourea in subcutaneously implanted 9L glioma using the apparent diffusion coefficient of water and 23Na MRI.
Babsky AM; Hekmatyar SK; Zhang H; Solomon JL; Bansal N
J Magn Reson Imaging; 2006 Jul; 24(1):132-9. PubMed ID: 16758478
[TBL] [Abstract][Full Text] [Related]
14. Synergistic cytotoxicity of the ribonucleotide reductase inhibitor didox (3,4-dihydroxy-benzohydroxamic acid) and the alkylating agent carmustine (BCNU) in 9L rat gliosarcoma cells and DAOY human medulloblastoma cells.
Horvath Z; Höchtl T; Bauer W; Fritzer-Szekeres M; Elford HL; Szekeres T; Tihan T
Cancer Chemother Pharmacol; 2004 Aug; 54(2):139-45. PubMed ID: 15133626
[TBL] [Abstract][Full Text] [Related]
15. Glioma-specific cytotoxic T cells can be effectively induced by subcutaneous vaccination of irradiated wild-type tumor cells without artificial cytokine production.
Iwadate Y; Yamaura A; Sakiyama S; Sato Y; Tagawa M
Int J Oncol; 2003 Aug; 23(2):483-8. PubMed ID: 12851699
[TBL] [Abstract][Full Text] [Related]
16. Effect of caffeine on cytotoxicity and sister chromatid exchange induction in sensitive and resistant rat brain tumor cells treated with 1,3-bis(2-chloroethyl)-1-nitrosourea.
Aida T; Bodell WJ
Cancer Res; 1987 Oct; 47(19):5052-8. PubMed ID: 3621190
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of the antitumor therapeutic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea by alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor.
Marton LJ; Levin VA; Hervatin SJ; Koch-Weser J; McCann PP; Sjoerdsma A
Cancer Res; 1981 Nov; 41(11 Pt 1):4426-31. PubMed ID: 6796258
[TBL] [Abstract][Full Text] [Related]
18. Effects of dicyclohexylamine sulfate, a spermidine synthase inhibitor, in 9L rat brain tumor cells.
Feuerstein BG; Deen DF; Marton LJ
Cancer Res; 1985 Oct; 45(10):4950-4. PubMed ID: 3928144
[TBL] [Abstract][Full Text] [Related]
19. Immunological responsiveness to interleukin-2-producing brain tumors can be restored by concurrent subcutaneous transplantation of the same tumors.
Iwadate Y; Tagawa M; Namba H; Oga M; Kawamura K; Tasaki K; Sakiyama S; Yamaura A
Cancer Gene Ther; 2000 Sep; 7(9):1263-9. PubMed ID: 11023199
[TBL] [Abstract][Full Text] [Related]
20. Assessment of ganciclovir toxicity to experimental intracranial gliomas following recombinant adenoviral-mediated transfer of the herpes simplex virus thymidine kinase gene by magnetic resonance imaging and proton magnetic resonance spectroscopy.
Ross BD; Kim B; Davidson BL
Clin Cancer Res; 1995 Jun; 1(6):651-7. PubMed ID: 9816028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
